Gadolinium-based contrast agents: stimulators of myeloid-induced renal fibrosis and major metabolic disruptors.

Evidence for gadolinium-based contrast agent-(GBCA-) induced disease continues to mount. Risk factors for gadolinium-induced systemic fibrosis are entirely unexplored. Obesity-related renal injury is characterized by activation of glomerular mesangial cells and podocyte damage with alteration of lip...

Full description

Saved in:
Bibliographic Details
Published in:Toxicol Appl Pharmacol
Main Authors: Do, Catherine, Ford, Bridget, Lee, Doug Yoon, Tan, Chunyan, Escobar, Patricia, Wagner, Brent
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6588162/
https://ncbi.nlm.nih.gov/pubmed/31082427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.taap.2019.05.009
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items